Twist Bioscience Corp (TWST)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $7.40B
Last updated: Nov 17, 2026 at 11:06 AM ET
Twist Bioscience Corp (TWST) Competitors
The companies most similar to Twist Bioscience are Bio-Techne (TECH), BridgeBio Pharma (BBIO) and Krystal Biotech (KRYS). By market cap, Twist Bioscience ranks 10th of the 13 companies on this page; BridgeBio Pharma (BBIO) is the largest at $15.25B. The median P/E of the 5 companies with a P/E is 40.4x.
Peer Comparison
TWST's revenue growth of 27.9% is below the peer median of 42.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Twist Bioscience (TWST) | $7.40B | N/A | 14.3x | -28.3% | N/A | 27.9% | 0.00% |
| Bio-Techne Corp (TECH) | $11.44B | 39.6x | 9.3x | 14.0% | 7.7% | 4.6% | 0.44% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| Krystal Biotech Inc (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| Spyre Therapeutics Inc. (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Cogent Biosciences Inc (COGT) | $4.97B | N/A | N/A | 0.0% | -43.4% | -100.0% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Cytokinetics Inc (CYTK) | $7.82B | N/A | 65.3x | 0.0% | -66.0% | 2357.0% | 0.00% |
| Crispr Therapeutics AG (CRSP) | $4.10B | N/A | 155.2x | 0.0% | -20.3% | 1325.0% | 0.00% |
| Axsome Therapeutics Inc (AXSM) | $7.45B | N/A | 8.6x | -18.2% | -48.1% | 51.9% | 0.00% |
| Peer median | $8.80B | 40.4x | 15.8x | 0.0% | -33.0% | 42.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Twist Bioscience, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Bio-Techne Corp (TECH) | Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments... | TECH competitors |
| BridgeBio Pharma Inc (BBIO) | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
| Krystal Biotech Inc (KRYS) | Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United... | KRYS competitors |
| Spyre Therapeutics Inc. (SYRE) | Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by... | SYRE competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
| Cogent Biosciences Inc (COGT) | Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. | COGT competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Cytokinetics Inc (CYTK) | Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering... | CYTK competitors |
| Crispr Therapeutics AG (CRSP) | CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. | CRSP competitors |
| Axsome Therapeutics Inc (AXSM) | Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United... | AXSM competitors |
Frequently Asked Questions About TWST
Who are Twist Bioscience's main competitors?
The companies most similar to Twist Bioscience include Bio-Techne (TECH), BridgeBio Pharma (BBIO), Krystal Biotech (KRYS), Spyre Therapeutics (SYRE) and Summit Therapeutics (SMMT), listed from the closest match.
Who is Twist Bioscience's biggest competitor?
BridgeBio Pharma (BBIO) is the largest of the similar companies at $15.25B; Bio-Techne (TECH) is the closest match by business profile, size, sector and industry.
How does TWST stock compare with its competitors?
TWST's P/S is 14.3x against a peer median of 15.8x; its net margin is -28.3% against a peer median of 0.0%.
Which of Twist Bioscience's competitors pays a higher dividend?
Twist Bioscience pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.
Is Twist Bioscience bigger than its competitors?
No. Twist Bioscience is 10th by market cap among the 13 companies on this page; the largest is BridgeBio Pharma (BBIO) at $15.25B.
TWST pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts